The novel coronavirus (severe acute
respiratory syndrome coronavirus 2, or SARSCoV-
2), which has caused the COVID-19 pandemic,
precipitated a major global crisis not seen in over
a century. In less than two months, the coronavirus
had spread to more than 100 countries, resulting
in about 1 million infections and a considerable
number of deaths globally. Despite having a lower
fatality rate than SARS, MERS, and Ebola, SARSCoV-
2 infects humans faster than other hazardous
virus. The number of cases and deaths had reached roughly 140 million and 3 million, respectively, by
the middle of April 2021.1
As a result of the disconcerting rates of
human suffering, several governments implemented
unprecedented non-pharmaceutical interventions
to suppress the spread and limit the loss, including
broad and targeted lockdowns, border restrictions,
and such smart strategies as diagnostic testing,
contact tracing, and isolation, as well as social
distancing and the wearing of face masks. Their
effectiveness in compromising the severity of the
pandemic has been empirically recognized in the
epidemiological literature (Anderson et al., 2020;
Cowling et al., 2020).
Aside from the health and life concerns, the
pandemic has had a devastating negative impact
on the global economy in a variety of ways. First,
COVID-19 infections cause a substantial decline
in the workforces because many employees and
workers must be isolated or hospitalized, implying
a supply constraint. Second, stringent measures to
prevent contagion from overwhelming the capacity
of a country’s healthcare system, such as social
distancing, lockdowns, and quarantines, ultimately
impede a large amount of economic activity. The
sudden disruption triggers a vicious cascading chain:
workplace and factory closures, layoffs, income
declines, spending cuts, and suspended investment
(Eichenbaum et al., 2020; Gourinchas, 2020). Third,
the shock amplifies pressure on borrowing costs